When the biosimilar regulatory framework was first introduced in the European Union (EU) in 2004, the whole thing was a "new mess," says Finnish Medicines Agency senior researcher Niklas Ekman.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?